. Motif analysis of SLC and ABC genes in iBMECs. Related to Figure 1 . These sequence motifs are highly enriched when analyzing all SLC and ABC genes that are identified in our healthy control iBMECs. P-values represent the likelihood of finding the calculated enrichment of that motif in random sequences with similar GC content. 
Supplemental Experimental Procedures
Statistical Analysis. Multiple statistical models were used to test the data based on data parameters. For each experiment a description of the statistical model used can be found within the figure legend or methods. Statistical significance is denoted by * < 0.05, ** < 0.01, *** < 0.001. Sample sizes and statistical tests for each experiment were chosen based on previous expertise and knowledge from past experiments using similar model systems, mice and iPSCs, and current accepted standards based on literature review. An estimation of variation within control or HD samples was assessed based on the statistical model used or data acquired, and accounted for in each experiment. No significant differences were detected between control samples. Control values were then combined for further comparison to HD samples. Also see Table S10 .
Generation and characterization of human non-integrating iPSCs using episomal plasmids
Fibroblasts were reprogrammed into non-integrating and virus-free iPSC lines as described (Mattis et al., 2015) using the Amaxa Human Dermal Fibroblast Nucleofector Kit to express episomal plasmids with six factors: OCT4, SOX2, KLF4, L-MYC, LIN28, and p53 shRNA (Addgene) (Mattis et al., 2015) . Nomenclature reflects the 1) last two digits of parental lines identifier, 2) non-disease or HD line, 3) CAG repeat number, and 4) clone number (Mattis et al., 2015) . Human iPSCs were rigorously characterized at the Cedars-Sinai iPSC core. G-Band karyotyping ensured normal a karyotype and genomic DNA PCR confirmed the absence of episomal plasmid genes, as described (Muller et al., 2011; Okita et al., 2011; Sareen et al., 2012) . Pluripotency was assessed by immunostaining with surface and nuclear pluripotency markers for subsequent flow cytometry quantification (> 80% SSEA4 and Oct3/4 double positivity), by quantitative RT-PCR of endogenous pluripotency genes, and by gene-chip and bioinformatics-based PluriTest assays. Spontaneous embryoid body differentiation confirmed the capacity to form all germ layers. Additional HD lines (66Q, 71Q) were also generated and characterized using the same methods from either primary patient fibroblasts obtained from the University of California, Irvine under IRB protocol #2008-6556 (66Q) or from the Coriell NINDS Repository (71Q, GM04281) under approved consent and privacy guidelines (Mattis et al., 2015) . CAG repeat lengths were determined following reprogramming and included in TableS1 & S2. All procedures were performed in accordance with the institutional review board's guidelines at the Cedars-Sinai Medical Center under the auspice IRB-SCRO Protocols Pro00028429 (Transplantation iPSC-derived human neural progenitors), Pro00021505, and Pro00032834.
Maintenance and differentiation of human iPSC-derived BMECs and iNPCs cells.
Briefly, iPSCs underwent spontaneous differentiation for 6 days in unconditioned medium (UM). The mixed cultures were then switched to human endothelial cell medium (Life Technologies) with bFGF (R&D Systems) and 1% platelet-poor plasma derived bovine serum (Alfa Aesar) to select for BMEC colony expansion and maturation for 2 days. During this time the samples were treated with retinoic acid (RA, Sigma). All cells were then plated onto collagen-IV (Sigma) and fibronectin (Corning) coated tissue culture plates or 0.4 µM 12 well transwell filters for 2-3 days to reach confluence before characterization and use in various assays. For iNPCs cells EZ spheres were dissociated in Accutase and plated down on to matrigel coated plates or tranwell inserts.
Immunofluorescence & CLDN5 puncta. After 2-3 days of growth on collagen IV and fibronectin coated chamber slides, cells were washed once with PBS and fixed in either 4% paraformaldehyde, 100% ice-cold methanol, or ice-cold 95% ethanol followed by 80% icecold acetone. Following fixation cells were blocked in 10% goat serum with 1% BSA and 0.1% triton X-100 (where applicable) for 1 hour at room temperature. Cells were then labeled with primary antibody overnight at 4 degrees, washed three times with PBS and treated with a fluorescently labeled secondary antibody for 1 hour at room temperature. Cells were counterstained with DAPI to visualize nuclei. Image J was used to quantify intracellular CLDN5 puncta using 3 images per a differentiation at 100x.
RNAseq and DE Statistics.
Total RNA was isolated from cells with the Qiagen RNeasy Kit using a QIAshredder for cell lysis and all RIN values were >9. RNA-Seq libraries were made with 1ug of RNA using the Illumina TruSeq mRNA v2 protocol. Libraries were quantified using the KAPA library quant kit and sequenced on the HiSeq 2500 using 75 cycles to obtain paired-end reads 75 base pairs in length. Paired-end reads were trimmed using a base quality score threshold of >20 and aligned to the hg19 genome with Tophat 2. RNA-Seq data were analyzed using quality control metrics, including: quality score trimming, base composition, k-mer content, and 5' and 3'-bias. Counts per gene were quantified using HTseq and analyzed with the R package DESeq2, or Partek Flow, to identify differentially expressed genes. 10% and 5% false discovery rate cutoffs were used for significance for DESeq2 and Partek Flow, respectively.
Exploratory, pathway, and motif analysis of DEGs.
For exploratory analysis plots GENE-E and Partek GS 6.6 were used for hierarchical clustering (Spearman's Ranked Correlation) and heatmap generation, and PCA of log2 transformed global expression values, respectively. Data were analyzed through the use of QIAGEN's Ingenuity® Pathway Analysis (IPA®, QIAGEN Redwood City, www.qiagen.com/ingenuity) for pathway analysis and upstream regulator analysis. Cytoscape was used to visualize GO analysis networks from BinGO, Enrichment Map, and CluGO (Bindea et al., 2009; Maere et al., 2005; Merico et al., 2010; Shannon et al., 2003) . EnrichR was used for additional pathway analysis to obtain ChEA and ENCODE ChIPSeq enrichments (Chen et al., 2013; Kuleshov et al., 2016) . Motif analysis was performed on a 1000bp region upstream of each gene's TSS, as reported by RefSeq, which were taken from the hg19 genome. Background sequences were created by sampling the genome for the same number of random 1000bp regions of matched GC content (in the case of the healthy BMEC analysis) or by using the upstream regions from the opposite treatment group (when comparing HD patient-derived cells to healthy-patient derived cells). THEME (Macisaac et al., 2006) was used to find enriched motifs in the upstream regions over the background sequences. The set of motif hypotheses is derived from all vertebrate-specific scoring matrices (PSSMs) from TRANSFAC (Wingender et al., 1996) and the human HT-SELEX compendium (Jolma et al., 2013) , filtered for sufficient information content (>9 total bits). Motif hypotheses were then clustered according to similar binding site motifs, and the top p-value for all motifs in a cluster is reported. Statistical analysis of SLC-and ABC genes were calculated using one-tailed p-value with a Chi squared test with Yates' correction.
Efflux and transporter Assays. For uptake assays cells were allowed to reach confluence on 6 well plate 2 days post subculture. The upper chamber medium was replaced with medium containing either 10 µM rhodamine 123 (Life Technologies) or 10 mM albumin-594 (Life Technogies) and incubated for 1 hour at 37 degrees C. After incubation cells were trypsinized, fixed with 4% PFA, and analyzed using flow cytometry for mean fluorescence. Gating were set using unstained and FMO controls. Puromycin efflux was measured based on cell death by allowing the BMECs to grow for 48 hours post subculture in normal 12 well TC plates with subsequent treatment with either 0.5 or 1 µM puromycin. After 48 hours of treatment cells were washed once with PBS and fixed with 4% PFA. After fixation cells were then washed and DAPI stained to visualize cell nuclei. ImageJ software was used to quantify cell counts from five images per a well using 3 wells per an experimental set and over 4 experiments.
Human Tissues. Western analysis primary antibodies were incubated in RIPA buffer containing protease inhibitors (HALT; Thermofisher), sonicated, concentrations determined by the Bradford method (Biorad), and suspended in Laemelli's sample buffer. 20ug protein per sample were electrophoresed on 4-15% acrylamide gels and probed with primary antibodies against human CLDN-5, OCCLUDIN, β-ACTIN (Invitrogen), SOX17 (Abcam). For IHC Deparaffinized sections underwent antigen retrieval for 35 min at 100°C (Target Retrieval Solution, pH 6; Dako, Carpinteria, CA). Peroxidase activity was quenched with 3% H2O2 for 10 min. Sections were blocked with 2.5% horse serum, incubated with SOX17 (Acris, Rockville, MD, Catalog # TA500281 at 1:25) for 18 h at 4°C, followed by ImmPRESS anti-mouse Ig peroxidase (Vector Labs, Burlingame, CA) and development with peroxidaseconjugated 3,3'-diaminobenzidine (Catalog # SK-4100; Vector Labs, Burlingame, CA). Washes were performed with 0.1% Tween-20 in PBS. Sections were counterstained with hematoxylin, then dehydrated and mounted with Permount. Images were captured using a Zeiss Axiomager microscope equipped with DIC optics using 20X objectives, Accumulation of DAB reaction product in endothelial nuclei was scored as 0=none detected, 1+=low, 2+=moderate, 3+=high.
